image
Tempest Therapeutics, Inc. TPST
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.8899
-8.27 %
$ 38.8 M
Market Cap
-0.56
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-29.2 M OPERATING INCOME
15.83%
Growth Rates
1Year 15.83%
3Years -14.75%
5Years -4.75%
7Years 12.73%
10Years -0.01%
-29.5 M NET INCOME
17.41%
Growth Rates
1Year 17.41%
3Years -15.36%
5Years -1.64%
7Years 13.63%
10Years -0.15%
EFFICIENCY
Earnings Waterfall Tempest Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 381 K
Gross Profit -381 K
Operating Expenses 29.2 M
Operating Income -29.2 M
Other Expenses 334 K
Net Income -29.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 0 0 0 0.3 0.7 0.3 9.7 0 0
GROSS PROFIT
Cost Of Revenue 0.4 1.8 1.3 0.8 1.1 32 K 28 K 5.4 2.2 0 0 0
Gross Profit (0.4) (1.8) (1.3) (0.8) (1.1) 32 K 0.3 (4.7) (2.0) 9.7 0 0
OPERATING INCOME
Operating Expenses 29.2 34.6 27.0 19.3 44.3 23.1 20.5 70.9 70.0 47.9 29.1 13.5
Selling, General and Administrative Expenses 11.7 12.1 9.8 4.9 16.5 8.7 5.9 49.2 51.6 26.1 13.3 7.2
Research and Development Expenses 17.5 22.5 17.2 14.4 27.8 14.4 14.5 21.6 18.4 21.8 15.8 6.3
Operating Income (29.2) (34.6) (27.0) (19.3) (45.4) (23.1) (20.5) (75.6) (72.0) (47.9) (29.1) (13.5)
PRE-TAX INCOME
Interest Income Expense 1.4 1.6 1.3 0 (1.0) 0.1 0 0.7 0.4 0 0 0
Total Other Income (0.3) (1.1) (1.3) 90 K (21.2) (4.1) (64.1) (1.0) (1.1) (1.6) 90 K 19 K
Pre-Tax Income (29.5) (35.7) (28.3) (19.2) (44.6) (27.2) (84.6) (82.1) (73.1) (49.5) (29.0) (13.5)
NET INCOME
Tax Provision 0 1.1 1.2 90 K 1 K (0.2) 67 K 0.2 75 K (1.6) 90 K 0
Net Income (29.5) (36.8) (29.6) (19.1) (44.6) (27.2) (84.6) (82.3) (73.2) (49.5) (29.0) (13.5)
EPS 1.91 3.18 7.8 613 48.8 264 72.4 K 576 608 492 289 2.33